These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35692401)

  • 21. The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease.
    Zhang L; Li H; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
    BMC Cancer; 2012 Dec; 12():610. PubMed ID: 23256514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid Antibody Status is Associated with Central Lymph Node Metastases in Papillary Thyroid Carcinoma Patients with Hashimoto's Thyroiditis.
    Wen X; Wang B; Jin Q; Zhang W; Qiu M
    Ann Surg Oncol; 2019 Jun; 26(6):1751-1758. PubMed ID: 30937662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasonic Feature Prediction of Large-Number Central Lymph Node Metastasis in Clinically Node-Negative Solitary Papillary Thyroid Carcinoma.
    Xiao W; Hu X; Zhang C; Qin X
    Endocr Res; 2023 Oct; 48(4):112-119. PubMed ID: 37606889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of prediction models for determining the risk of lateral lymph node metastasis in patients with thyroid papillary carcinoma based on gender stratification.
    Wu WX; Qi GF; Feng JW; Ye J; Hong LZ; Wang F; Liu SY; Jiang Y
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2511-2523. PubMed ID: 36622416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Patient and Tumor Characteristics on Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Guide for Selective Node Dissection.
    Altiner S; Kozan R; Emral AC; Taneri F; Karamercan A
    Arch Iran Med; 2022 Nov; 25(11):730-736. PubMed ID: 37543897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of nomograms for predicting the risk of central lymph node metastasis of solitary papillary thyroid carcinoma of the isthmus.
    Li Y; Gao X; Guo T; Liu J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14853-14868. PubMed ID: 37598343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors of central lymph node metastasis in cN0 papillary thyroid carcinoma: a study of 529 patients.
    Liang K; He L; Dong W; Zhang H
    Med Sci Monit; 2014 May; 20():807-11. PubMed ID: 24831428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto's thyroiditis.
    Zhu Y; Zheng K; Zhang H; Chen L; Xue J; Ding M; Wu K; Wang Z; Kong L; Chen X
    Tumour Biol; 2016 Jun; 37(6):8037-45. PubMed ID: 26711787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of a nomogram for central lymph node metastasis in papillary thyroid cancer based on gender grouping.
    Qi GF; Feng JW; Wu WX; Ye J; Hu J; Wang F; Hong LZ; Liu SY; Jiang Y
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):965-975. PubMed ID: 37975909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.
    Chang Q; Zhang J; Wang Y; Li H; Du X; Zuo D; Yin D
    Front Endocrinol (Lausanne); 2022; 13():937049. PubMed ID: 35909521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An integrated nomogram combining deep learning, clinical characteristics and ultrasound features for predicting central lymph node metastasis in papillary thyroid cancer: A multicenter study.
    Chang L; Zhang Y; Zhu J; Hu L; Wang X; Zhang H; Gu Q; Chen X; Zhang S; Gao M; Wei X
    Front Endocrinol (Lausanne); 2023; 14():964074. PubMed ID: 36896175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.
    Wang M; Li R; Zou X; Wei T; Gong R; Zhu J; Li Z
    Medicine (Baltimore); 2020 Aug; 99(35):e21996. PubMed ID: 32871952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
    Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0).
    Gao X; Luo W; He L; Cheng J; Yang L
    Front Endocrinol (Lausanne); 2021; 12():789310. PubMed ID: 35154002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomograms for Prediction of High-Volume Lymph Node Metastasis in Papillary Thyroid Carcinoma Patients.
    Feng JW; Ye J; Qi GF; Hong LZ; Hu J; Wang F; Liu SY; Jiang Y
    Otolaryngol Head Neck Surg; 2023 May; 168(5):1054-1066. PubMed ID: 36856043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Nomogram Based on Clinical and Ultrasound Characteristics to Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
    Feng JW; Hong LZ; Wang F; Wu WX; Hu J; Liu SY; Jiang Y; Ye J
    Front Endocrinol (Lausanne); 2021; 12():666315. PubMed ID: 33995284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma.
    Wei X; Min Y; Feng Y; He D; Zeng X; Huang Y; Fan S; Chen H; Chen J; Xiang K; Luo H; Yin G; Hu D
    J Endocrinol Invest; 2022 Mar; 45(3):507-515. PubMed ID: 34491546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomogram for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Retrospective Cohort Study of Two Clinical Centers.
    Yang Z; Heng Y; Lin J; Lu C; Yu D; Tao L; Cai W
    Cancer Res Treat; 2020 Oct; 52(4):1010-1018. PubMed ID: 32599980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk prediction for central lymph node metastasis in isolated isthmic papillary thyroid carcinoma by nomogram: A retrospective study from 2010 to 2021.
    Zhao Y; Shi W; Dong F; Wang X; Lu C; Liu C
    Front Endocrinol (Lausanne); 2022; 13():1098204. PubMed ID: 36733797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections.
    Li M; Zhu XY; Lv J; Lu K; Shen MP; Xu ZL; Wu ZS
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3801-3807. PubMed ID: 28975988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.